Neurion Pharmaceuticals, Inc.

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

27 documents for Neurion Pharmaceuticals, Inc.

- Neurion Pharmaceuticals, Inc. Wins $500,000 NIMH SBIR Grant to Develop New Drugs for Anxiety.
PASADENA, Calif. -- Neurion Pharmaceuticals, Inc., an ion channel drug discovery company, announced today that it has been awarded a $500,000 Phase I ...
- Business Wire
- June 02, 2005
- Neurion Pharmaceuticals Inc.
Health Care - Brief Article
- Los Angeles Business Journal
- September 27, 2004
- Neurion Pharmaceuticals, Inc. Appoints Paul B. Bennett, Ph.D., as Vice President, Discovery.
PASADENA, Calif. -- Neurion Pharmaceuticals, Inc., an ion channel drug discovery company, announced today that Dr. Paul B. Bennett, Jr., formerly of M...
- Business Wire
- September 20, 2004

- Neurion Wins Grant for Anxiety Research
Neurion Pharmaceuticals Inc., a research drug company, announced Thursday that it has been awarded a $500,000 Phase I grant under the Small Business Innovation Research Program administered by the National Institute of Mental Health. Neurion is using the grant to support its ongoing development of safer and more effective drugs to treat anxiety.
- San Gabriel Valley Tribune
- February 01, 2006
- Neurion Pharmaceuticals, Inc., Appoints Mark J. Suto, Ph.D., to Position of Executive V.P. and Chief Scientific Officer.
Business Editors/Health/Medical Writers BIOWIRE2K PASADENA, Calif.--(BUSINESS WIRE)--March 20, 2003 Neurion Pharmaceuticals, Inc. (www.neurionph...
- Business Wire
- March 20, 2003
- Neurion Pharmaceuticals, Inc. Renews and Expands Collaboration on HERG Ion Channel and Drug Development with Pfizer Inc.
Business Editors/Health/Medical Writers BIOWIRE2K PASADENA, Calif.--(BUSINESS WIRE)--Jan. 8, 2004 Neurion Pharmaceuticals, Inc., an ion channel ...
- Business Wire
- January 08, 2004
- Neurion Pharmaceuticals, Inc. Signs Research Agreement with Pfizer Inc. to Model Drug Interactions with the HERG Ion Channel, a Well-Known Source of Drug Toxicity.
Business Editors & Health/Medical Writers BIOWIRE2K LOS ANGELES--(BUSINESS WIRE)--Jan. 15, 2003 Neurion Pharmaceuticals, Inc. (www.neurionpharma...
- Business Wire
- January 15, 2003
- Neurion Pharmaceuticals, Inc. Scientific Advisor Robert H. Grubbs Wins 2005 Nobel Prize in Chemistry.
PASADENA, Calif. -- Neurion Pharmaceuticals, Inc., an ion channel drug discovery company, announced today its congratulations to Dr. Robert H. Grubbs,...
- Business Wire
- October 11, 2005
- Neurion Pharmaceuticals, Inc., Appoints Michael C. Sanguinetti, Professor of Physiology at the Univ. of Utah and an Expert in Ion Channel Pharmacology, to Its Scientific Advisory Board.
Business Editors/Health/Medical Writers BIOWIRE2K PASADENA, Calif.--(BUSINESS WIRE)--March 12, 2003 Neurion Pharmaceuticals, Inc. (www.neurionph...
- Business Wire
- March 12, 2003
- Neurion Pharmaceuticals, Inc. Announces CNS Drug Discovery Alliance with Eli Lilly and Company.
Business Editors/Health/Medical Writers BIOWIRE2K PASADENA, Calif.--(BUSINESS WIRE)--July 8, 2003 Neurion Pharmaceuticals, Inc. (www.neurionphar...
- Business Wire
- July 08, 2003